Creating designer antimicrobials; peptidoglycan hydrolase module shuffling
US7982003B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 6, 2009 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Jul 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2795/00011
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention concerns a nucleic acid encoding a recombinant bifunctional fusion peptidoglycan hydrolase protein formed from a nucleic acid encoding a peptidoglycan hydrolase module and a nucleic acid encoding a second peptidoglycan hydrolase module. The fusion, dual (or multiples thereof) peptidoglycan hydrolase modules can be used to treat disease caused by the bacteria for which the individual modules of the fusion protein are specific.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.